Rewriting the story
of human health — 

one cell at a time

Empowering biomedical innovation and a new generation of cures through precision reprogrammed human cells

Cell identity coding platform

Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency.

Therapeutics

Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.

ioCells™

Precision reprogrammed human iPSC-derived cells for research and drug discovery.

iocells_vial_radial_0

Latest news

bit.bio partners with Automata on key aspect of human cell production Press Release
bit.bio partners with Automata on key aspect of human cell production 26.01.2023
Published by Automata
Read now
Key opinions - biotech in 2023: reasons for optimism CEO views
Key opinions - biotech in 2023: reasons for optimism 16.01.2023
Published by Labiotech.eu
Read now
Article
"Science Meets Design" episode on synthetic biology 23.12.2022
Published by Science Meets Design
Read now
Three new products for neurological and neurodegenerative disease New product
Three new products for neurological and neurodegenerative disease 23.11.2022
Published by bit.bio
Read now